Femoral hypoplasia - unusual facies syndrome

Known as: Femoral hypoplasia unusual facies syndrome, Femoral-Facial Syndrome, FHUFS 
 
National Institutes of Health

Related topics

Related topics

20 relations
Cleft PalateCongenital clubfootCryptorchidismEsotropia
(More)

Broader (2)

FemurPierre Robin Syndrome

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.
The 1996 Five-Factor Score (FFS) for systemic necrotizing vasculitides (polyarteritis nodosa [PAN], microscopic polyangiitis [MPA… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2010
Review
2010
Congenital hypothyroidism
Congenital hypothyroidism (CH) occurs in approximately 1:2,000 to 1:4,000 newborns. The clinical manifestations are often subtle… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Prevalence of multiple chronic conditions in the United States' Medicare population
In 2006, the Centers for Medicare & Medicaid Services, which administers the Medicare program in the United States, launched the… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Fast Asymmetric Learning for Cascade Face Detection
A cascade face detector uses a sequence of node classifiers to distinguish faces from nonfaces. This paper presents a new… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.
Germinal center (GC) and non-GC phenotypes are predictors of outcome in diffuse large B-cell lymphoma (DLBCL) and can be used to… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
PURPOSE To address early and late treatment failures in older patients with diffuse large B-cell lymphoma (DLBCL), we designed a… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine…
PURPOSE To determine the response, failure-free survival (FFS), and overall survival rates and toxicity of rituximab plus an… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.
PURPOSE To identify risk factors associated with outcomes in children with metastatic rhabdomyosarcoma (RMS) treated on the… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
PURPOSE The study goal was to improve outcome in children with rhabdomyosarcoma by comparing risk-based regimens of surgery… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
We undertook this study to determine the clinical, biologic, immunologic, and therapeutic factors associated with the prognoses… (More)
Is this relevant?